Bioinformatics screening revealed that TRMT6 is highly expressed in high-grade gliomas and is involved in regulating the cell cycle and the PI3K-AKT, TGF-β, MTORC1, NOTCH, and MYC pathways to promote glioma proliferation. This evidence concerns the gene TGFB1 and central nervous system cancer.